Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The association between the apolipoprotein A1/ high density lipoprotein -cholesterol and diabetes in Taiwan - a cross-sectional study.

Jian ZH, Lung CC, Ko PC, Sun YH, Huang JY, Ho CC, Ho CY, Chiang YC, Chen CJ, Liaw YP.

BMC Endocr Disord. 2013 Oct 7;13:42. doi: 10.1186/1472-6823-13-42.

2.
4.

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.

Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.

Circulation. 2005 Nov 29;112(22):3375-83.

5.

The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk.

Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B.

J Clin Endocrinol Metab. 2010 Sep;95(9):4345-53. doi: 10.1210/jc.2010-0361. Epub 2010 Jul 14.

PMID:
20631030
6.

Relationship between anthropometric variables and lipid levels among school children: The Taipei Children Heart Study.

Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM.

Int J Obes Relat Metab Disord. 1998 Jan;22(1):66-72.

PMID:
9481602
7.

Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1.

Kim SW, Jee JH, Kim HJ, Jin SM, Suh S, Bae JC, Kim SW, Chung JH, Min YK, Lee MS, Lee MK, Kim KW, Kim JH.

Int J Cardiol. 2013 Oct 3;168(3):2678-83. doi: 10.1016/j.ijcard.2013.03.027. Epub 2013 Mar 29.

PMID:
23545148
8.

Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.

Yin RX, Wu DF, Miao L, Htet Aung LH, Cao XL, Yan TT, Long XJ, Liu WY, Zhang L, Li M.

Biofactors. 2013 May-Jun;39(3):315-25. doi: 10.1002/biof.1073. Epub 2013 Jan 28.

PMID:
23355348
9.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
10.

Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.

Yin RX, Wu DF, Miao L, Aung LH, Cao XL, Yan TT, Long XJ, Liu WY, Zhang L, Li M.

Cardiovasc Diabetol. 2012 Oct 8;11:123. doi: 10.1186/1475-2840-11-123.

11.

Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study.

Seo MH, Bae JC, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Lee WY.

J Clin Endocrinol Metab. 2011 Dec;96(12):E2050-4. doi: 10.1210/jc.2011-1857. Epub 2011 Oct 12.

PMID:
21994961
12.

Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity.

Ying X, Qian Y, Jiang Y, Jiang Z, Song Z, Zhao C.

Acta Diabetol. 2012 Dec;49(6):465-72. doi: 10.1007/s00592-012-0419-9. Epub 2012 Sep 11.

PMID:
22965469
13.

Associations between smoking, components of metabolic syndrome and lipoprotein particle size.

Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, Boezen HM, Dullaart RP, Kobold AC, Feskens EJ, van Beek AP, van der Klauw MM, Wolffenbuttel BH.

BMC Med. 2013 Sep 3;11:195. doi: 10.1186/1741-7015-11-195.

14.

Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.

Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X.

Cardiovasc Diabetol. 2014 Oct 20;13:146. doi: 10.1186/s12933-014-0146-3.

15.

Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: different profiles according to low-density lipoprotein cholesterol.

Kim SJ, Park YG, Kim JH, Han YK, Cho HK, Bang OY.

Atherosclerosis. 2012 Aug;223(2):463-7. doi: 10.1016/j.atherosclerosis.2012.05.011. Epub 2012 May 19.

PMID:
22683121
16.

Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.

Hisamatsu T, Fujiyoshi A, Miura K, Ohkubo T, Kadota A, Kadowaki S, Kadowaki T, Yamamoto T, Miyagawa N, Zaid M, Torii S, Takashima N, Murakami Y, Okamura T, Horie M, Ueshima H; SESSA Research Group.

Atherosclerosis. 2014 Oct;236(2):237-43. doi: 10.1016/j.atherosclerosis.2014.07.019. Epub 2014 Jul 25.

PMID:
25105580
17.

Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters.

Pan J, Gao F, Bao Y, Zhang L, Tu Y, Jia W.

J Clin Lipidol. 2012 Jul-Aug;6(4):382-7. doi: 10.1016/j.jacl.2012.01.008. Epub 2012 Jan 28.

PMID:
22836076
18.

Effects of ezetimibe/simvastatin 10/20 mg vs. atorvastatin 20 mg on apolipoprotein B/apolipoprotein A1 in Korean patients with type 2 diabetes mellitus: results of a randomized controlled trial.

Lee JH, Kang HJ, Kim HS, Sohn DW, Oh BH, Park YB.

Am J Cardiovasc Drugs. 2013 Oct;13(5):343-51. doi: 10.1007/s40256-013-0031-6.

PMID:
23728830
19.

Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.

Yin RX, Li YY, Lai CQ.

Lipids Health Dis. 2011 Aug 19;10:140. doi: 10.1186/1476-511X-10-140.

20.

Lipid, lipoprotein, and apolipoprotein profiles in active and sedentary men with tetraplegia.

Dallmeijer AJ, Hopman MT, van der Woude LH.

Arch Phys Med Rehabil. 1997 Nov;78(11):1173-6.

PMID:
9365344

Supplemental Content

Support Center